Every clinical outcome at every future time point.
Predicted with unparalleled precision.
Every clinical outcome at every future time point.
Predicted with unparalleled precision.
Know the future health of every participant at the beginning of your clinical study.
.webp)
We create digital twins of your patients using clinical trial data
Delivered through a
state-of-the-art, easy to useplatform
That minimizes trial failure, cuts costs, andaccelerates approval.
Solutions
What can the Unlearn Platform do for you?
Discover how the Unlearn Platform can enhance your trial’s efficiency, insights, and impact, tailored to your needs. Explore a few of our solutions below and book a demo to learn how we can support your trial goals.
Solutions
What can Unlearn do for you?
Discover how Unlearn can enhance your trial’s efficiency, insights, and impact, tailored to your needs. Explore a few of our solutions below and book a demo to discuss how we can support your study.
01.
Accelerate Timelines with Smaller, More Efficient Studies
Design and run smaller clinical trials that maintain power or more powerful studies without requiring additional participants. This approach is qualified by the EMA and aligns with current FDA guidance.
02.
Enhance Decision-Making with Digital Twins
Explore predicted outcomes for any subgroup of participants for all measured clinical variables at any point in time. Access real-time insights and make more informed, data-driven decisions throughout the study.
03.
Identify Sensitive Clinical Outcomes
Generate participants’ digital twins resembling your study’s target patient population during trial planning to optimize study endpoints and composite scores, enhancing sensitivity at both the population and subpopulation levels.
The Unlearn Platform
Control Arm Size Reduction*
33
%
Estimated Cost Savings*
$
50
M
*Approximate values
Accelerating Clinical Development in Alzheimer’s Disease
We work in neuroscience, immunology, metabolic disease, and more.
View Case Study
Featured Highlights
Newsroom
Stay Informed with the Latest in AI Innovation, Clinical Research, Industry Commentary, and Thought Leadership
Sign in